Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,015,921
-
Share change
-
+771,163
-
Total reported value
-
$8,643,000
-
Price per share
-
$2.86
-
Number of holders
-
10
-
Value change
-
+$2,223,301
-
Number of buys
-
4
-
Number of sells
-
1
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q4 2014
As of 31 Dec 2014,
RECRO PHARMA INC - COM (SCTL) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,015,921 shares.
The largest 10 holders included
Broadfin Capital, LLC, SABBY MANAGEMENT, LLC, Cormorant Asset Management, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Ancora Advisors, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), and BlackRock Investment Management, LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.